Amyloid-beta

Assets acting on this target.

Class
Therapeutic active immunotherapy vaccine
Notes
hand ruling, audit finding #971; ACI-24.060 is an active vaccine; the stored target's parenthetical calls it a monoclonal antibody, which is the opposite modality; source: https://www.acimmune.com/pipeline/aci-24-060/

By indication

Related mechanisms

Amyloid-beta drugs compared

4 drugs, stage by indication
4 drugs acting on Amyloid-beta: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
AV-1959RNuravax, Inc.Biologic (active vaccine)Phase 2Phase 2 in Alzheimer's Disease
UB-311VaxxinityvaccinePhase 2Phase 2 in Early Alzheimer's Disease
ACI-24.060AC ImmuneBiologic (liposomal active vaccine)Phase 1/2Not recorded
ALZ-101Alzinova ABBiologic (active vaccine)Phase 1Phase 1 in Alzheimer's Disease

← all mechanisms